Director, Business Development

Endpoint is a leading interactive response technology (IRT®) systems and solutions provider supporting the life sciences industry. Since 2009, we’ve partnered with sponsors and pharmaceutical companies to drive clinical trial success through precision, speed, and operational excellence.

Our proprietary PULSE® platform enables optimized clinical supply chains, reduced operational costs, and accurate patient dosing across complex global studies. We are also advancing our next-generation platform, Elosity, a more flexible, scalable, and data-driven solution designed to enhance trial execution and strengthen long-term customer value.

Headquartered in Raleigh-Durham, North Carolina, Endpoint operates globally with offices across the United States, Europe, and Asia—supporting clients at every stage of the clinical development lifecycle.